Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme

Morris D. Groves, Vinay K. Puduvalli, Kenneth R. Hess, Kurt A. Jaeckle, Pamela Peterson, W. K.Alfred Yung, Victor A. Levin

Research output: Contribution to journalArticlepeer-review

203 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme'. Together they form a unique fingerprint.

Medicine & Life Sciences